go back

South Dakota rates for HCPCS Q0173

Trimethobenzamide HCl, 250 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Facilitymedian $1 · 10th–90th $0$10%20%10th90th$1Professionalmedian $1 · 10th–90th $1$10%20%10th90th$1$0.5$1.0$2.0$5.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$7.08
Median
$7.08
Typical High
$7.94
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.76
Median
$0.83
Typical High
$0.93
Medica
Setting
Facility
Modifier
Global
Typical Low
$0.36
Median
$0.51
Typical High
$0.87
Medica
Setting
Professional
Modifier
Global
Typical Low
$0.76
Median
$0.83
Typical High
$4.37
Midlands
Setting
Professional
Modifier
Global
Typical Low
$0.98
Median
$1.10
Typical High
$1.51
Midlands
Setting
Professional
Modifier
Global
Typical Low
$1.15
Median
$1.15
Typical High
$1.15
United
Setting
Professional
Modifier
Global
Typical Low
$0.83
Median
$0.83
Typical High
$1.07